- Home
- SCVL vs FDMT Comparison
SCVL vs FDMT Comparison
Compare SCVL & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCVL | FDMT |
|---|---|---|
| Founded | 1978 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 511.9M | 431.4M |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SCVL | FDMT |
|---|---|---|
| Price | $18.81 | $8.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | N/A | ★ $34.29 |
| AVG Volume (30 Days) | 496.6K | ★ 744.2K |
| Earning Date | 03-19-2026 | 02-27-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $1,144,197,000.00 | $120,000.00 |
| Revenue This Year | N/A | $21,227.03 |
| Revenue Next Year | N/A | $161.87 |
| P/E Ratio | $9.16 | ★ N/A |
| Revenue Growth | N/A | ★ 605.88 |
| 52 Week Low | $15.21 | $2.24 |
| 52 Week High | $29.76 | $12.34 |
Technical Indicators
Market Signals| Indicator | SCVL | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 52.40 |
| Support Level | $18.40 | $7.77 |
| Resistance Level | $20.18 | $8.25 |
| Average True Range (ATR) | 0.76 | 0.55 |
| MACD | 0.00 | 0.17 |
| Stochastic Oscillator | 48.45 | 80.41 |
Price Performance
Historical ComparisonAbout SCVL Shoe Carnival Inc.
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.